Clinical and Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2023-08-21 1481ab03m35(暂无昵称) 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：生物医学;合成生物学;癌症治疗
经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长；
第一投稿，格式审查一周；
第二，编辑部审查1周到两周；
第三，外审2到4周；
第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期；
第五，小修，修会后先格式审查，再编辑部审查；
第六，接受，校稿，缴费
第七，In production 等出版

192 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2021-12-07 ms5000002112552282

求问under initial checking6天，直接pending decision是要凉了吗

57 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2024-04-14 ms3000001338909804 来自湖北省

偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗
经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…

2 0

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2024-04-14 ms4000000418941187 来自广东省

偏重的研究方向：肿瘤基础研究;肿瘤
经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2024-01-15 ms4000001214643575 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：基因组测序;肿瘤
经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗

16 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2024-02-23 科研小白白白白alz 来自湖北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：神经系统疾病
经验分享：审稿人偏多，一般5-6个（可能同时找10几个）
01-Nov-2023 submit；
25-Nov-2023 major revision（五个审稿人，给两个月时间）；
30-Jan-2024 revision submit；
19-Feb-2024 minor revision（二审加送一个审稿人）；
21-Feb-2024 revision submit；
22-Feb-2024 accept

70 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2024-01-18 victorjohn 来自江苏省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。

13 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2024-03-11 ms2000000319329547 来自北京

一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2021-04-03 148c69cbm40暂无昵称

审稿速度:2.0 | 投稿命中率:25.0
经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online

195 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生物医学;合成生物学;癌症治疗 经验分享：整体投稿流程较为顺利，但是各个时间节点周期较长； 第一投稿，格式审查一周； 第二，编辑部审查1周到两周； 第三，外审2到4周； 第四，大修，修回后先格式审查，再编辑部审查，再回到审稿人处审稿，基本1到2个月周期； 第五，小修，修会后先格式审查，再编辑部审查； 第六，接受，校稿，缴费 第七，In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1077699, encodeId=b28d10e76991a, content=求问under initial checking6天，直接pending decision是要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Tue Dec 07 11:25:17 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198461, encodeId=a741219846107, content=偏重的研究方向：肿瘤;肿瘤临床基础;癌症治疗 经验分享：2024.1.8投稿 under initial checking 2024.1.13变为under review 2024.1.25变为pending recommendation 2024.2.6变为major revision，三个审稿人，两个小修一个大修，编辑给了大修，给了两个月时间。每个审稿人5个左右问题，补了两个大实验，现在已返修回去，求好运…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Sun Apr 14 16:14:56 CST 2024, time=2024-04-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198346, encodeId=6583219834660, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：求教各位大佬，投稿8天，pending decision 6天还没消息，这是要直接拒吗？还是有可能送审呀？没投过pending这个状态持续这么久的😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Sun Apr 14 00:22:24 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基因组测序;肿瘤 经验分享：一审回来给了两个月，补实验时间有点紧，实在补不完，想申请延期一个月，多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复，现在系统已经没有提交返修的选项了，还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经系统疾病 经验分享：审稿人偏多，一般5-6个（可能同时找10几个） 01-Nov-2023 submit； 25-Nov-2023 major revision（五个审稿人，给两个月时间）； 30-Jan-2024 revision submit； 19-Feb-2024 minor revision（二审加送一个审稿人）； 21-Feb-2024 revision submit； 22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：一审返回了15个审稿人意见，家人们，太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天，二审32天，pending 25天，现在三审，已经pending 11天了，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：第一次投稿没有送外审被编辑直接拒稿但是副编辑给了修改为letter重新投的机会于是修改为letter后重新投稿送外审一审一个月左右小修修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向：肿瘤 经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省)]

2023-10-17 a201061519 来自河南省

偏重的研究方向：肿瘤
经验分享：期刊现在文章水平越来越高了！非常有潜力股的期刊～

25 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务